Investigation of β-lactam antibiotic-induced vancomycin-resistant MRSA (BIVR)

Journal of Infection and Chemotherapy

Volumn 11, Issue 2, 2005, Pages 104-106

  Hanaki, Hideaki ^a   Yamaguchi, Yoshio ^a   Yanagisawa, Chie ^a   Uehara, Kazuaki ^a   Matsui, Hidehito ^a   Yamaguchi, Yukie ^a   Hososaka, Yasuko ^b   Barada, Kazunari ^c   Sakai, Fumiko ^c   Itabashi, Yasuko ^c   Ikeda, Shinsuke ^c   Atsuda, Koichiro ^c   Tanaka, Haruo ^c   Inamatsu, Takashi ^d   Nagayama, Ariaki ^e   Sunakawa, Keisuke ^c  

^a KITASATO INSTITUTE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KITASATO UNIVERSITY   (Japan)

^d Tokyo Metropolitan Institute of Gerontology   (Japan)

^e FUKUOKA UNIVERSITY   (Japan)

Author keywords

Antagonism; BIVR; Vancomycin; Lactam antibiotics

Indexed keywords

BETA LACTAM ANTIBIOTIC; GLUTAMIC ACID DERIVATIVE; PEPTIDOGLYCAN; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE N ACETYLMURAMIC ACID; URIDINE DIPHOSPHATE N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMYLLYSINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM DETECTION; BACTERIUM ISOLATE; CONTROLLED STUDY; JAPAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; STAPHYLOCOCCUS AUREUS;

EID: 20844455771     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-004-0371-x     Document Type: Article

References (18)

1. Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Hori S, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997;350:1670-3.
2. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997;40:135-6.
3. Hanaki H, Kuwahara-Arai K, Boyle-Vavra S, Daum RS, Labischinski H, Hiramatsu K. Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50. J Antimicrob Chemother 1998;42:199-209.
4. Hanaki H, Labischinski H, Inaba Y, Kondo N, Murakami H, Hiramatsu K. Increase in glutamine-non-amidated muropeptides in the peptidoglycan of vancomycin-resistant Staphylococcus aureus strain Mu50. J Antimicrob Chemother 1998;42:315-20.
5. Hanaki H, Inaba Y, Sasaki K, Hiramatsu K. A novel method of detecting Staphylococcus aureus heterogeneously resistant to vancomycin (hetero-VRSA). Jpn J Antibiot 1998;51:521-30.
6. Aritaka N, Hanaki H, Cui L, Hiramatsu K. Combination effect of vancomycin and beta-lactams against a Staphylococcus aureus strain, Mu3, with heterogeneous resistance to vancomycin. Antimicrob Agents Chemother 2001;45:1292-4.
7. Howe RA, Wootton M, Bennett PM, MacGowan AP, Walsh TR. Interactions between methicillin and vancomycin in methicillin-resistant Staphylococcus aureus strains displaying different phenotypes of vancomycin susceptibility. J Clin Microbiol 1999;37:3068-71.
8. Kim MN, Hwang SH, Pyo YJ, Mun HM, Pai CH. Clonal spread of Staphylococcus aureus heterogeneously resistant to vancomycin in a university hospital in Korea. J Clin Microbiol 2002;40:1376-80.
9. Kim YS, Kiem S, Yun HJ, Jung SI, Oh WS, Kim SW, et al. Efficacy of vancomycin-beta-lactam combinations against heterogeneously vancomycin-resistant Staphylococcus aureus (hetero-VRSA). J Korean Med Sci 2003;18:319-24.
10. Hanaki H, Inaba Y, Sasaki K, Hiramatsu K. A novel method of detecting Staphylococcus aureus heterogeneously resistant to vancomycin (hetero-VRSA). Jpn J Antibio 1998;8:521-30.
11. Hanaki H, Hiramatsu K. Antibiotic resistance methods and protocols. Detection methods of glycopeptide-resistant Staphylococcus aureus. Parts 1-9. In: Stephen H. Gillespie, editor. Susceptibility test methods in molecular medicine, TM/48. New Jersey: Humana; 2000. pp. 85-91.
12. Hanaki H, Yamaguchi Y, Nomura S, Haraga I, Nagayama A, Sunakawa K. Method of detecting "β-lactam antibiotic induced vancomycin resistant MRSA (BIVR)". Int J Antimicrob Agents 2004;23:1-5.
13. Hanaki H, Yamaguchi Y, Barata K, Sakai H, Sunakawa K. Improved method of detection of "β-lactam antibiotic-induced VCM-resistant MRSA" (BIVR). Int J Antimicrob Agents 2004;23: 310-12.
14. Howe RA, Wootton M, Walsh TR, Bennett PM, MacGowan AP. Expression and detection of hetero-vancomycin resistance in Staphylococcus aureus. J Antimicrob Chemother 1999;44:675-8.
15. Ike Y, Arakawa Y, Ma X, Tatewaki K, Nagasawa M, Tomita H, et al. Nationwide survey shows that methicillin-resistant Staphylococcus aureus strains heterogeneously and intermediately resistant to vancomycin are not disseminated throughout Japanese hospitals. J Clin Microbiol 2001;39:4445-51.
16. Yamaguchi Y, Hanaki H, Barada K, Inamatsu T, Sunakawa K. Epidemiological investigation of MRSA with antagonistic effects of beta-lactam antibiotic and vancomycin. Kansenshogaku Zasshi 2003;77:661-6.
17. Jacobs C. Life in the balance: cell walls and antibiotic resistance. Science 1997;278:1731-2.
18. Archer GL, Bosilevac JM. Microbiology. Signaling antibiotic resistance in staphylococci. Science 2001;291:1915-16.